APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bupropion Hydrochloride Extended-Release Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Bupropion Hydrochloride Extended-Release Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025196 pages

Choose your research edition.

Industry ResearchBupropion Hydrochloride Extended-Release Tablets Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Bupropion Hydrochloride Extended-Release Tablets Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Bupropion Hydrochloride Extended-Release Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bupropion Hydrochloride Extended-Release Tablets Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Bupropion Hydrochloride Extended-Release Tablets Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Bupropion Hydrochloride Extended-Release Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Bupropion Hydrochloride Extended-Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bupropion Hydrochloride Extended-Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bupropion Hydrochloride Extended-Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Bupropion Hydrochloride Extended-Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bupropion Hydrochloride Extended-Release Tablets include Annora Pharma, Dr. Reddy's, Epic Pharma, Granules India, Impax Laboratories, ProPhase, Teva Pharmaceuticals, Valeant International Barbados SRL and Disha, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bupropion Hydrochloride Extended-Release Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bupropion Hydrochloride Extended-Release Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bupropion Hydrochloride Extended-Release Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bupropion Hydrochloride Extended-Release Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Bupropion Hydrochloride Extended-Release Tablets Segment by Company

Annora Pharma

Dr. Reddy's

Epic Pharma

Granules India

Impax Laboratories

ProPhase

Teva Pharmaceuticals

Valeant International Barbados SRL

Disha

GlaxoSmithKline

Shenyang Funing Pharmaceutical

Venturepharm Pharmacetical

Sinotherapeutics

Yichang Humanwell Pharmaceutical

Bupropion Hydrochloride Extended-Release Tablets Segment by Type

150mg

300mg

Bupropion Hydrochloride Extended-Release Tablets Segment by Application

Pharmacy

Hospital

Clinic

Bupropion Hydrochloride Extended-Release Tablets Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bupropion Hydrochloride Extended-Release Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bupropion Hydrochloride Extended-Release Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bupropion Hydrochloride Extended-Release Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bupropion Hydrochloride Extended-Release Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bupropion Hydrochloride Extended-Release Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Bupropion Hydrochloride Extended-Release Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Bupropion Hydrochloride Extended-Release Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Bupropion Hydrochloride Extended-Release Tablets Industry Trends Table 2. Bupropion Hydrochloride Extended-Release Tablets Industry Drivers Table 3. Bupropion Hydrochloride Extended-Release Tablets Industry Opportunities and Challenges Table 4. Bupropion Hydrochloride Extended-Release Tablets Industry Restraints Table 5. Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Bupropion Hydrochloride Extended-Release Tablets Sales by Manufacturers (Units) & (2021-2026) Table 8. Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Manufacturers Table 9. Global Bupropion Hydrochloride Extended-Release Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Bupropion Hydrochloride Extended-Release Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Bupropion Hydrochloride Extended-Release Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Bupropion Hydrochloride Extended-Release Tablets Manufacturers, Product Type & Application Table 13. Global Bupropion Hydrochloride Extended-Release Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Bupropion Hydrochloride Extended-Release Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 150mg Table 17. Major Manufacturers of 300mg Table 18. Global Bupropion Hydrochloride Extended-Release Tablets Sales by Type 2021 VS 2025 VS 2032 (Units) Table 19. Global Bupropion Hydrochloride Extended-Release Tablets Sales by Type (2021-2026) & (Units) Table 20. Global Bupropion Hydrochloride Extended-Release Tablets Sales by Type (2027-2032) & (Units) Table 21. Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Type (2021-2026) Table 22. Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Type (2027-2032) Table 23. Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Type 2021 VS 2025 VS 2032 (Units) Table 24. Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Type (2021-2026) & (Units) Table 25. Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Type (2027-2032) & (Units) Table 26. Global Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Pharmacy Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Clinic Table 31. Global Bupropion Hydrochloride Extended-Release Tablets Sales by Application 2021 VS 2025 VS 2032 (Units) Table 32. Global Bupropion Hydrochloride Extended-Release Tablets Sales by Application (2021-2026) & (Units) Table 33. Global Bupropion Hydrochloride Extended-Release Tablets Sales by Application (2027-2032) & (Units) Table 34. Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Application (2021-2026) Table 35. Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Application (2027-2032) Table 36. Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Application 2021 VS 2025 VS 2032 (Units) Table 37. Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Application (2021-2026) & (Units) Table 38. Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Application (2027-2032) & (Units) Table 39. Global Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Application (2021-2026) Table 40. Global Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Application (2027-2032) Table 41. Global Bupropion Hydrochloride Extended-Release Tablets Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 42. Global Bupropion Hydrochloride Extended-Release Tablets Sales by Region (2021-2026) & (Units) Table 43. Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Region (2021-2026) Table 44. Global Bupropion Hydrochloride Extended-Release Tablets Sales Forecasted by Region (2027-2032) & (Units) Table 45. Global Bupropion Hydrochloride Extended-Release Tablets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Bupropion Hydrochloride Extended-Release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 47. North America Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2021-2026) & (Units) Table 48. North America Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2027-2032) & (Units) Table 49. Europe Bupropion Hydrochloride Extended-Release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 50. Europe Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2021-2026) & (Units) Table 51. Europe Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2027-2032) & (Units) Table 52. Asia Pacific Bupropion Hydrochloride Extended-Release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 53. Asia Pacific Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2021-2026) & (Units) Table 54. Asia Pacific Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2027-2032) & (Units) Table 55. South America, Middle East and Africa Bupropion Hydrochloride Extended-Release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 56. South America, Middle East and Africa Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2021-2026) & (Units) Table 57. South America, Middle East and Africa Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2027-2032) & (Units) Table 58. Global Bupropion Hydrochloride Extended-Release Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Region (2021-2026) Table 62. Global Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Region (2027-2032) Table 63. Annora Pharma Company Information Table 64. Annora Pharma Business Overview Table 65. Annora Pharma Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Annora Pharma Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 67. Annora Pharma Recent Development Table 68. Dr. Reddy's Company Information Table 69. Dr. Reddy's Business Overview Table 70. Dr. Reddy's Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Dr. Reddy's Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 72. Dr. Reddy's Recent Development Table 73. Epic Pharma Company Information Table 74. Epic Pharma Business Overview Table 75. Epic Pharma Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Epic Pharma Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 77. Epic Pharma Recent Development Table 78. Granules India Company Information Table 79. Granules India Business Overview Table 80. Granules India Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Granules India Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 82. Granules India Recent Development Table 83. Impax Laboratories Company Information Table 84. Impax Laboratories Business Overview Table 85. Impax Laboratories Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Impax Laboratories Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 87. Impax Laboratories Recent Development Table 88. ProPhase Company Information Table 89. ProPhase Business Overview Table 90. ProPhase Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. ProPhase Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 92. ProPhase Recent Development Table 93. Teva Pharmaceuticals Company Information Table 94. Teva Pharmaceuticals Business Overview Table 95. Teva Pharmaceuticals Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Teva Pharmaceuticals Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 97. Teva Pharmaceuticals Recent Development Table 98. Valeant International Barbados SRL Company Information Table 99. Valeant International Barbados SRL Business Overview Table 100. Valeant International Barbados SRL Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Valeant International Barbados SRL Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 102. Valeant International Barbados SRL Recent Development Table 103. Disha Company Information Table 104. Disha Business Overview Table 105. Disha Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Disha Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 107. Disha Recent Development Table 108. GlaxoSmithKline Company Information Table 109. GlaxoSmithKline Business Overview Table 110. GlaxoSmithKline Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. GlaxoSmithKline Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 112. GlaxoSmithKline Recent Development Table 113. Shenyang Funing Pharmaceutical Company Information Table 114. Shenyang Funing Pharmaceutical Business Overview Table 115. Shenyang Funing Pharmaceutical Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Shenyang Funing Pharmaceutical Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 117. Shenyang Funing Pharmaceutical Recent Development Table 118. Venturepharm Pharmacetical Company Information Table 119. Venturepharm Pharmacetical Business Overview Table 120. Venturepharm Pharmacetical Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Venturepharm Pharmacetical Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 122. Venturepharm Pharmacetical Recent Development Table 123. Sinotherapeutics Company Information Table 124. Sinotherapeutics Business Overview Table 125. Sinotherapeutics Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Sinotherapeutics Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 127. Sinotherapeutics Recent Development Table 128. Yichang Humanwell Pharmaceutical Company Information Table 129. Yichang Humanwell Pharmaceutical Business Overview Table 130. Yichang Humanwell Pharmaceutical Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Yichang Humanwell Pharmaceutical Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 132. Yichang Humanwell Pharmaceutical Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Bupropion Hydrochloride Extended-Release Tablets Distributors List Table 136. Bupropion Hydrochloride Extended-Release Tablets Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Bupropion Hydrochloride Extended-Release Tablets Product Image Figure 2. Global Bupropion Hydrochloride Extended-Release Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bupropion Hydrochloride Extended-Release Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Bupropion Hydrochloride Extended-Release Tablets Sales (2021-2032) & (Units) Figure 5. Global Bupropion Hydrochloride Extended-Release Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Bupropion Hydrochloride Extended-Release Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 150mg Image Figure 9. 300mg Image Figure 10. Global Bupropion Hydrochloride Extended-Release Tablets Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 11. Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Type (2021 VS 2025 VS 2032) & (Units) Figure 14. Global Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Type (2021-2032) Figure 16. Pharmacy Image Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Global Bupropion Hydrochloride Extended-Release Tablets Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 20. Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Application (2021-2032) Figure 22. Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Application (2021 VS 2025 VS 2032) & (Units) Figure 23. Global Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Bupropion Hydrochloride Extended-Release Tablets Sales and Growth Rate (2021-2032) & (Units) Figure 26. North America Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Country (2021-2032) Figure 27. U.S. Bupropion Hydrochloride Extended-Release Tablets Sales and Growth Rate (2021-2032) & (Units) Figure 28. Canada Bupropion Hydrochloride Extended-Release Tablets Sales and Growth Rate (2021-2032) & (Units) Figure 29. Mexico Bupropion Hydrochloride Extended-Release Tablets Sales and Growth Rate (2021-2032) & (Units) Figure 30. Europe Bupropion Hydrochloride Extended-Release Tablets Sales and Growth Rate (2021-2032) & (Units) Figure 31. Europe Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Country (2021-2032) Figure 32. Germany Bupropion Hydrochloride Extended-Release Tablets Sales and Growth Rate (2021-2032) & (Units) Figure 33. France Bupropion Hydrochloride Extended-Release Tablets Sales and Growth Rate (2021-2032) & (Units) Figure 34. U.K. Bupropion Hydrochloride Extended-Release Tablets Sales and Growth Rate (2021-2032) & (Units) Figure 35. Italy Bupropion Hydrochloride Extended-Release Tablets Sales and Growth Rate (2021-2032) & (Units) Figure 36. Netherlands Bupropion Hydrochloride Extended-Release Tablets Sales and Growth Rate (2021-2032) & (Units) Figure 37. Asia Pacific Bupropion Hydrochloride Extended-Release Tablets Sales and Growth Rate (2021-2032) & (Units) Figure 38. Asia Pacific Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Country (2021-2032) Figure 39. China Bupropion Hydrochloride Extended-Release Tablets Sales and Growth Rate (2021-2032) & (Units) Figure 40. Japan Bupropion Hydrochloride Extended-Release Tablets Sales and Growth Rate (2021-2032) & (Units) Figure 41. South Korea Bupropion Hydrochloride Extended-Release Tablets Sales and Growth Rate (2021-2032) & (Units) Figure 42. Southeast Asia Bupropion Hydrochloride Extended-Release Tablets Sales and Growth Rate (2021-2032) & (Units) Figure 43. India Bupropion Hydrochloride Extended-Release Tablets Sales and Growth Rate (2021-2032) & (Units) Figure 44. Australia Bupropion Hydrochloride Extended-Release Tablets Sales and Growth Rate (2021-2032) & (Units) Figure 45. South America, Middle East and Africa Bupropion Hydrochloride Extended-Release Tablets Sales and Growth Rate (2021-2032) & (Units) Figure 46. South America, Middle East and Africa Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Country (2021-2032) Figure 47. Brazil Bupropion Hydrochloride Extended-Release Tablets Sales and Growth Rate (2021-2032) & (Units) Figure 48. South Africa Bupropion Hydrochloride Extended-Release Tablets Sales and Growth Rate (2021-2032) & (Units) Figure 49. Saudi Arabia Bupropion Hydrochloride Extended-Release Tablets Sales and Growth Rate (2021-2032) & (Units) Figure 50. Turkey Bupropion Hydrochloride Extended-Release Tablets Sales and Growth Rate (2021-2032) & (Units) Figure 51. Argentina Bupropion Hydrochloride Extended-Release Tablets Sales and Growth Rate (2021-2032) & (Units) Figure 52. UAE Bupropion Hydrochloride Extended-Release Tablets Sales and Growth Rate (2021-2032) & (Units) Figure 53. Egypt Bupropion Hydrochloride Extended-Release Tablets Sales and Growth Rate (2021-2032) & (Units) Figure 54. Chile Bupropion Hydrochloride Extended-Release Tablets Sales and Growth Rate (2021-2032) & (Units) Figure 55. Global Bupropion Hydrochloride Extended-Release Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Bupropion Hydrochloride Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Figure 58. North America Bupropion Hydrochloride Extended-Release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Bupropion Hydrochloride Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Bupropion Hydrochloride Extended-Release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Bupropion Hydrochloride Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Bupropion Hydrochloride Extended-Release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Bupropion Hydrochloride Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Bupropion Hydrochloride Extended-Release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Bupropion Hydrochloride Extended-Release Tablets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Bupropion Hydrochloride Extended-Release Tablets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 150mg
  • 300mg
Applications
  • Pharmacy
  • Hospital
  • Clinic
Companies covered
  • Annora Pharma
  • Dr. Reddy's
  • Epic Pharma
  • Granules India
  • Impax Laboratories
  • ProPhase
  • Teva Pharmaceuticals
  • Valeant International Barbados SRL
  • Disha
  • GlaxoSmithKline
  • Shenyang Funing Pharmaceutical
  • Venturepharm Pharmacetical
  • Sinotherapeutics
  • Yichang Humanwell Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Bupropion Hydrochloride Extended-Release Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Bupropion Hydrochloride Extended-Release Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Bupropion Hydrochloride Extended-Release Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Bupropion Hydrochloride Extended-Release Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Bupropion Hydrochloride Extended-Release Tablets Market Dynamics
  1. 2.1 Bupropion Hydrochloride Extended-Release Tablets Industry Trends
  2. 2.2 Bupropion Hydrochloride Extended-Release Tablets Industry Drivers
  3. 2.3 Bupropion Hydrochloride Extended-Release Tablets Industry Opportunities and Challenges
  4. 2.4 Bupropion Hydrochloride Extended-Release Tablets Industry Restraints
3 Bupropion Hydrochloride Extended-Release Tablets Market by Manufacturers
  1. 3.1 Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Bupropion Hydrochloride Extended-Release Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Bupropion Hydrochloride Extended-Release Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bupropion Hydrochloride Extended-Release Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Bupropion Hydrochloride Extended-Release Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Bupropion Hydrochloride Extended-Release Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bupropion Hydrochloride Extended-Release Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bupropion Hydrochloride Extended-Release Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bupropion Hydrochloride Extended-Release Tablets Tier 1, Tier 2, and Tier 3
4 Bupropion Hydrochloride Extended-Release Tablets Market by Type
  1. 4.1 Bupropion Hydrochloride Extended-Release Tablets Type Introduction
  2. 4.1.1 150mg
  3. 4.1.2 300mg
  4. 4.2 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Type
  5. 4.2.1 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Type
  9. 4.3.1 Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Type (2021-2032)
5 Bupropion Hydrochloride Extended-Release Tablets Market by Application
  1. 5.1 Bupropion Hydrochloride Extended-Release Tablets Application Introduction
  2. 5.1.1 Pharmacy
  3. 5.1.2 Hospital
  4. 5.1.3 Clinic
  5. 5.2 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Application
  6. 5.2.1 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Application
  10. 5.3.1 Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Application (2021-2032)
6 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Region
  1. 6.1 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Bupropion Hydrochloride Extended-Release Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Bupropion Hydrochloride Extended-Release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Bupropion Hydrochloride Extended-Release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Bupropion Hydrochloride Extended-Release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Bupropion Hydrochloride Extended-Release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Region
  1. 7.1 Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Region
  2. 7.1.1 Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Bupropion Hydrochloride Extended-Release Tablets Revenue (2021-2032)
  8. 7.2.2 North America Bupropion Hydrochloride Extended-Release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Bupropion Hydrochloride Extended-Release Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Bupropion Hydrochloride Extended-Release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Bupropion Hydrochloride Extended-Release Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Bupropion Hydrochloride Extended-Release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Bupropion Hydrochloride Extended-Release Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Bupropion Hydrochloride Extended-Release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Annora Pharma
  2. 8.1.1 Annora Pharma Company Information
  3. 8.1.2 Annora Pharma Business Overview
  4. 8.1.3 Annora Pharma Bupropion Hydrochloride Extended-Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Annora Pharma Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  6. 8.1.5 Annora Pharma Recent Developments
  7. 8.2 Dr. Reddy's
  8. 8.2.1 Dr. Reddy's Company Information
  9. 8.2.2 Dr. Reddy's Business Overview
  10. 8.2.3 Dr. Reddy's Bupropion Hydrochloride Extended-Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Dr. Reddy's Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  12. 8.2.5 Dr. Reddy's Recent Developments
  13. 8.3 Epic Pharma
  14. 8.3.1 Epic Pharma Company Information
  15. 8.3.2 Epic Pharma Business Overview
  16. 8.3.3 Epic Pharma Bupropion Hydrochloride Extended-Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Epic Pharma Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  18. 8.3.5 Epic Pharma Recent Developments
  19. 8.4 Granules India
  20. 8.4.1 Granules India Company Information
  21. 8.4.2 Granules India Business Overview
  22. 8.4.3 Granules India Bupropion Hydrochloride Extended-Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Granules India Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  24. 8.4.5 Granules India Recent Developments
  25. 8.5 Impax Laboratories
  26. 8.5.1 Impax Laboratories Company Information
  27. 8.5.2 Impax Laboratories Business Overview
  28. 8.5.3 Impax Laboratories Bupropion Hydrochloride Extended-Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Impax Laboratories Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  30. 8.5.5 Impax Laboratories Recent Developments
  31. 8.6 ProPhase
  32. 8.6.1 ProPhase Company Information
  33. 8.6.2 ProPhase Business Overview
  34. 8.6.3 ProPhase Bupropion Hydrochloride Extended-Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 ProPhase Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  36. 8.6.5 ProPhase Recent Developments
  37. 8.7 Teva Pharmaceuticals
  38. 8.7.1 Teva Pharmaceuticals Company Information
  39. 8.7.2 Teva Pharmaceuticals Business Overview
  40. 8.7.3 Teva Pharmaceuticals Bupropion Hydrochloride Extended-Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Teva Pharmaceuticals Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  42. 8.7.5 Teva Pharmaceuticals Recent Developments
  43. 8.8 Valeant International Barbados SRL
  44. 8.8.1 Valeant International Barbados SRL Company Information
  45. 8.8.2 Valeant International Barbados SRL Business Overview
  46. 8.8.3 Valeant International Barbados SRL Bupropion Hydrochloride Extended-Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Valeant International Barbados SRL Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  48. 8.8.5 Valeant International Barbados SRL Recent Developments
  49. 8.9 Disha
  50. 8.9.1 Disha Company Information
  51. 8.9.2 Disha Business Overview
  52. 8.9.3 Disha Bupropion Hydrochloride Extended-Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Disha Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  54. 8.9.5 Disha Recent Developments
  55. 8.10 GlaxoSmithKline
  56. 8.10.1 GlaxoSmithKline Company Information
  57. 8.10.2 GlaxoSmithKline Business Overview
  58. 8.10.3 GlaxoSmithKline Bupropion Hydrochloride Extended-Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 GlaxoSmithKline Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  60. 8.10.5 GlaxoSmithKline Recent Developments
  61. 8.11 Shenyang Funing Pharmaceutical
  62. 8.11.1 Shenyang Funing Pharmaceutical Company Information
  63. 8.11.2 Shenyang Funing Pharmaceutical Business Overview
  64. 8.11.3 Shenyang Funing Pharmaceutical Bupropion Hydrochloride Extended-Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Shenyang Funing Pharmaceutical Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  66. 8.11.5 Shenyang Funing Pharmaceutical Recent Developments
  67. 8.12 Venturepharm Pharmacetical
  68. 8.12.1 Venturepharm Pharmacetical Company Information
  69. 8.12.2 Venturepharm Pharmacetical Business Overview
  70. 8.12.3 Venturepharm Pharmacetical Bupropion Hydrochloride Extended-Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Venturepharm Pharmacetical Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  72. 8.12.5 Venturepharm Pharmacetical Recent Developments
  73. 8.13 Sinotherapeutics
  74. 8.13.1 Sinotherapeutics Company Information
  75. 8.13.2 Sinotherapeutics Business Overview
  76. 8.13.3 Sinotherapeutics Bupropion Hydrochloride Extended-Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Sinotherapeutics Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  78. 8.13.5 Sinotherapeutics Recent Developments
  79. 8.14 Yichang Humanwell Pharmaceutical
  80. 8.14.1 Yichang Humanwell Pharmaceutical Company Information
  81. 8.14.2 Yichang Humanwell Pharmaceutical Business Overview
  82. 8.14.3 Yichang Humanwell Pharmaceutical Bupropion Hydrochloride Extended-Release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Yichang Humanwell Pharmaceutical Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  84. 8.14.5 Yichang Humanwell Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bupropion Hydrochloride Extended-Release Tablets Value Chain Analysis
  2. 9.1.1 Bupropion Hydrochloride Extended-Release Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bupropion Hydrochloride Extended-Release Tablets Production Mode & Process
  6. 9.2 Bupropion Hydrochloride Extended-Release Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bupropion Hydrochloride Extended-Release Tablets Distributors
  9. 9.2.3 Bupropion Hydrochloride Extended-Release Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst